Bortezomib-Based Induction for Transplant Ineligible AL Amyloidosis and Feasibility of Later Transplantation

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2015.73
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Autologous Stem Cell Transplant in the Era of Bortezomib-Based Induction for AL Amyloidosis – A Single Institution 11 Year Experience

2018English

Efficacy of Bortezomib in Systemic AL Amyloidosis With Relapsed/Refractory Clonal Disease

Haematologica
Hematology
2008English

Combination of Bortezomib in the Induction, Conditioning and Consolidation With Autologous Hematopoietic Stem Cell Transplantation in Patients With Immunoglobulin Light Chain Amyloidosis

American Journal of Hematology
Hematology
2019English

Maintained Hematologic and Organ Responses Following Risk Adapted Stem Cell Transplant (SCT) in Systemic Light-Chain Amyloidosis (AL) Using Bortezomib and Dexamethasone as Consolidation Therapy

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Response of Bortezomib Chemotherapy in Hepatic Amyloidosis

Journal of Investigative Medicine High Impact Case Reports
RiskEpidemiologyReliabilitySafetySafety ResearchQuality
2018English

Bortezomib and Dexamethasone Consolidation Following Risk-Adapted Melphalan and Stem Cell Transplantation for Patients With Newly Diagnosed Light-Chain Amyloidosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

The Influence of Induction Therapy for Kidney Transplantation After a Non-Renal Transplant

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2011English

Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

New and Developing Therapies for AL Amyloidosis

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy